The World Health Organization does not have evidence that the monkeypox virus has mutated, a senior executive at the U.N. agency said on Monday, noting the infectious disease that has been endemic in west and central Africa has tended not to change.
Last week, a man in Massachusetts became the first person in the United States to be diagnosed with monkeypox since 2021. On May 22, U.S. health authorities announced they may have found the third documented case in a patient in South Florida.
The World Health Organization was due to hold an emergency meeting on May 20 to discuss the recent outbreak of monkeypox, a viral infection more common to west and central Africa, after more than 100 cases were confirmed or suspected in Europe.
The World Health Organization’s European chief said on May 20 he is concerned that the spread of monkeypox could accelerate in the region as people gather for parties and festivals over the summer months.
Pharmacy chains should pay $878 million for opioid epidemic role, Ohio counties say
CVS Health, Legal, Ohio, Opioid Epidemic, Opioid Litigation, Opioid Overdoses, Opioid Prescriptions, Opioid Safety, Opioids, Opioids, Overdoses, Prescriptions, Public Health Emergencies, Retail Pharmacies, Therapeutics, Wal-Mart Stores, Walgreens Boots AllianceA lawyer for two Ohio counties said CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. should fund an $878 million plan to address the opioid crisis there, as a first-of-its-kind trial got underway to determine the pharmacy chains’ contribution.
The Rockefeller Foundation injects $55 million to get Covid-19 shots from airports to arms
Africa, Asia, Caribbean, Coronavirus Disease 2019 (COVID-19), Coronavirus Vaccines, COVID-19 public health emergency, COVID-19 shots, COVID-19 Vaccinations, COVID-19 Vaccines, Foundations, Initiatives, Latin America, Public Health, Public Health Emergencies, Rockefeller Foundation, Therapeutics, VaccinationsThe Rockefeller Foundation announced the launch of the Global Vaccination Initiative, a $55 million investment over two years to support country-led efforts to fully vaccinate 90% of the most at-risk populations in Africa, Asia, Latin America, and the Caribbean.
Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against Endo
Business, Class Action Lawsuits, Endo, Lawsuits, Litigation, Opioid Litigation, Opioid Litigation, Opioid Overdoses, Opioid Prescriptions, Opioids, Opioids, Opioids, Opioids, Opioids, Overdoses, Overturned Verdicts, Prescriptions, Probes, Specialty Pharma, Substance Abuse, Tennessee, Therapeutics, U.S. Opioid CrisisEndo International plc announced that the Tennessee Court of Appeals reversed a trial court judge’s order denying a motion for recusal by Endo’s wholly owned subsidiaries Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. in Clay County et al. v. Purdue Pharma, L.P., et al, pending in the Circuit Court for Cumberland County, Tennessee, and remanded the case for transfer to a different judge.
The United States on April 13 renewed the COVID-19 public health emergency, allowing millions of Americans to keep getting free tests, vaccines and treatments for at least three more months.
Pear Therapeutics, Inc. has announced a program to offer patients seeking treatment for substance use disorder (SUD) or opioid use disorder (OUD) access to a telehealth provider through its “find a provider tool”, along with in-person care options.
WHO Tracking 4 Omicron Subvariants while a New Antibody Gets the Nod
Antivirals, Bebtelovimab (LY-CoV1404; LY3853113), BNT162b2 (Pfizer and BioNTech), CDC, Congress, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Antibodies, COVID-19 booster shots, COVID-19 protocols, COVID-19 shots, COVID-19 Vaccines, Covid-19 Variants, Eli Lilly, Emergency Use Authorization (EUA), FDA, Immunocompromised, JAMA Network, Janssen COVID-19 Vaccine (J&J), Joe Biden, Johnson & Johnson, Mask-wearing, Molnupiravir, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Omicron (B.1.1.529) (South Africa), Omicron BA.2, Paxlovid, Public Health Emergencies, R&D, Surgeon general, WHO, World Health OrganizationThe World Health Organization indicated WHO is tracking four Omicron subvariants: BA.1, BA.1.1, BA.2 and BA.3. BA.2 has a growth advantage over BA.1, the variant responsible for the recent Omicron surge.